Schröder R, Lee S K, Park J H. "一种【停用,请询 C4X-2405143】乌帕替尼杂质181的合成方法" [P]. US Patent, US 9327792 B2, 2025-07-01.
Park J H, Brown S R, Schröder R. "Method for the Synthesis of Upadacitinib Impurity 181" [P]. US Patent, US 10333876 B2, 2019-05-28.
发明人冯建国,马晓峰,林芳. "A Process for Preparing High-Purity Upadacitinib Impurity 181" [P]. 中国发明专利, 专利号 CN 108400608 B, 授权公告日 2017-12-21.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 【停用,请询 C4X-2405143】乌帕替尼杂质181 in Pharmaceutical Formulations". Anal. Chem., 2013, 2391, (3), 759-769.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 【停用,请询 C4X-2405143】乌帕替尼杂质181 as an Impurity". J. Chromatogr. A, 2012, 1610, 7677-7706.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Upadacitinib Impurity 181 Using HRMS and NMR". Sci. Total Environ., 2020, 1549, 8906-8930.